Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non–Small-Cell Lung Cancer: A Single-Center EvaluationToshihiro Iguchi, Susumu Kanazawa, Hideo Gobara et al.|Journal of Vascular and Interventional Radiology|2020Cited by 29
Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parametersKuniaki Katsui, Susumu Kanazawa, Takeshi Ogata et al.|Cancer Medicine|2020Cited by 22
Radiation therapy for oligometastatic bone disease in breast cancerNorihisa Katayama, Susumu Kanazawa, Kuniaki Katsui et al.|Translational Cancer Research|2020Cited by 7
3073 Clinical results of proton beam therapy for patients with HCC: A merit of the BCLC staging on prognosis predictionTakahiro Waki, Takao Hiraki, Norihisa Katayama et al.|Radiotherapy and Oncology|2025Cited by 0